We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This specification defines requirements for generating standard sticky labels with newborns' NHS numbers, to complete the newborn blood spot screening card.
This publication covers all 6 inherited metabolic diseases (IMDs) and incorporates the previous PKU and MCADD laboratory handbooks.
Instructions on how to submit key performance indicator (KPI) data for the antenatal and newborn blood spot (NBS) screening programmes.
To support conversations between blood sample takers and parents offered screening for severe combined immunodeficiency (SCID) for their baby.
Executive summary of the antenatal and newborn screening (ANNB) quality assurance (QA) visit to York Teaching Hospital NHS Trust held on 23 October 2019.
Executive summary of quality assurance visit to Great Western Hospitals NHS Foundation Trust's antenatal and newborn screening programme on 13 September 2016.
Executive summary of the quality assurance (QA) visit to Milton Keynes University Hospital NHS Foundation Trust ANNB screening programmes on 23 January 2020.
Executive summary of quality assurance (QA) visit to Weston Area Health NHS Trust's antenatal and newborn screening programmes held on 14 March 2017.
Executive summary of quality assurance (QA) visit to North West Anglia NHS Foundation Trust t held on 26 and 27 September 2018.
Executive summary of quality assurance (QA) visit to Provide Child Health Information Services held on 4 July 2018.
Executive summary of quality assurance (QA) visit to Manchester University NHS Foundation Trust held on 14 and 15 March 2018.
Executive summary of the antenatal and newborn screening (ANNB) quality assurance (QA) visit to North Bristol NHS Trust held on 5 November 2019.
Executive summary of quality assurance (QA) visit to Epsom and St Helier University Hospitals held on 10, 29 and 30 November 2016.
Executive summary of quality assurance (QA) visit to Royal Berkshire NHS Foundation Trust held on 26 June 2018.
Executive summary of quality assurance (QA) visit to North Midlands NHS Trust antenatal and newborn screening on 31 July 2019.
Guidance for laboratories on reporting newborn blood spot screen positive results to Child Health Information Service and Newborn Blood Spot Failsafe Solution
Executive summary of quality assurance (QA) visit to Western Sussex Hospitals NHS Foundation Trust antenatal and newborn screening on 3 and 4 June 2019.
Executive summary of the quality assurance (QA) visit to Barking, Havering and Redbridge University Hospitals NHS Trust on 12 and 13 February 2020.
This process explains how Public Health England (PHE) Screening produces publications for professionals and the public.
Executive summary of quality assurance (QA) visit to Mid Yorkshire Hospitals NHS Trust held on 24 October 2018.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).